🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1, 2-part double-blinded (with respect to NX-5948/placebo),...
Status
Completed
Location
Celerion
Start Date
2024-08-20
Trial ID
NCT06593457
Treatments Being Tested
This is a first-in-human Phase 1a/1b multicenter, open-label study designed...
Status
Recruiting
Location
City of Hope
Start Date
2022-04-13
Trial ID
NCT05131022
Treatments Being Tested
This is a study for patients with relapsed/refractory (R/R) chronic lymphoc...
Status
Recruiting
Location
City of Hope
Start Date
2025-10-15
Trial ID
NCT07221500
Treatments Being Tested
This is a Phase 1, 2-period, open-label, single-dose, fixed-sequence study ...
Status
Completed
Location
Celerion
Start Date
2024-11-01
Trial ID
NCT06691828
Treatments Being Tested
The study will evaluate the efficacy and safety of NX-5948 (bexobrutideg) v...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06
Trial ID
NCT07516093
Treatments Being Tested
This is a multiple part, multiple cohort study evaluating single and multip...
Status
Completed
Location
Celerion
Start Date
2024-11-30
Trial ID
NCT06717269
Treatments Being Tested
The study will evaluate NX-5948 (bexobrutideg) in combination with venetocl...
Status
Recruiting
Location
Rocky Mountain Cancer Centers
Start Date
2026-08
Trial ID
NCT07520006
Treatments Being Tested